Chr. Hansen Holding A/S

Chr. Hansen Holding A/S

Chr. Hansen Holding A/S

Overview
Date Founded

2004

Headquarters

Bøge Allé 10-12,Hørsholm, Capital Region 2970

Type of Company

Public

Employees (Worldwide)

3,111

Industries

Biotechnology

Company Description

Chr. Hansen Holding A/S is a bioscience company, which engages in the development of natural solutions for the food, nutritional, pharmaceutical, and agricultural industries. It operates through the following segments: Food Cultures and Enzymes; Health and Nutrition; and Natural Colors. The Food Cultures and Enzymes segment produces and sells cultures, enzymes, and probiotic products that help determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of consumer products in the food industry. The Health and Nutrition segment manufactures and distributes products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. The Natural Colors segment caters to the food and beverage industry. The company was founded by Christian Ditlev Ammentorp Hansen in 1874 and is headquartered in Hørsholm, Denmark.

Contact Data
Trying to get in touch with decision makers at Chr. Hansen Holding A/S? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Executive Vice President & Chief Financial Officer

Chief Scientific Officer & Executive Vice President

Executive Vice President & Chief Scientific Officer

Director

Director

Board of Directors

Former President, Europe Group at The Coca-Cola Company

Vice Chairman of the Board of Directors & Member of the Nomination & Audit Committee at Chr. Hansen A/S

Director at Chr. Hansen Holding A/S

Director at Chr. Hansen Holding A/S

Professional at Chr. Hansen Holding A/S

Director at Chr. Hansen Holding A/S

Director at Chr. Hansen Holding A/S

Director at Chr. Hansen Holding A/S

Chief Executive Officer at Heartland A/S

Chief Executive Officer at Good Food Group AS

Paths to Chr. Hansen Holding A/S
Potential Connections via
Relationship Science
You
Chr. Hansen Holding A/S
Owners & Shareholders
Details Hidden

GuardCap employs a fundamental, company selection-based process designed to create concentrated portfolios of companies, each having significantly better quality and growth characteristics than the market average, and each being undervalued in relation to its long-term future earnings and cash flows at the time of purchase. The firm offers a global equity strategy and a global emerging market equity strategy, both bound by the same investment philosophy, both concentrated, bottom-up investment strategies targeting significantly better returns than benchmarks.

Details Hidden

GLG-UK is an active, collaborative manager which aims to achieve consistent superior returns. They adhere to client-focused product development and customer service in both traditional and alternative asset management. The firm's fund managers express their individual investment styles and meet regularly with companies, brokers and consultants, analyzing quantitative models or completing their own proprietary research. They base investment decisions on fundamental research, tactical trading and a wide range of network of industry contacts and employ a rigorous risk management process.

Details Hidden

LFDE employs an active conviction-based management and manages a range of funds primarily invested in equities, corporate bonds and convertible bonds. The firm aims to create sustainable value and capture performance regardless of market configurations. Their management approach, based on an in-depth knowledge of companies, allows them to overcome market movements.

Recent Transactions
Details Hidden

Chr. Hansen Holding A/S purchases Jennewein Biotechnologie GmbH from Investitions- & Strukturbank Rheinland-Pfalz /Venture Capital

Details Hidden

Chr. Hansen Holding A/S purchases UAS Laboratories LLC from Greyrock Capital Group LLC, Lakeview Equity Partners LLC

Details Hidden

Chr. Hansen Holding A/S purchases Österreichische Laberzeugung Hundsbichler GmbH

Transaction Advisors
Legal Advisor

Advised onChr. Hansen Holding A/S purchases UAS Laboratories LLC from Greyrock Capital Group LLC, Lakeview Equity Partners LLC

Underwriter

Advised onChr. Hansen Holding A/S issued DKK Ordinary Shares

Underwriter

Advised onChr. Hansen Holding A/S issued DKK Ordinary Shares

Legal Advisor

Advised onChr. Hansen Holding A/S purchases UAS Laboratories LLC from Greyrock Capital Group LLC, Lakeview Equity Partners LLC

Legal Advisor

Advised onChr. Hansen Holding A/S purchases UAS Laboratories LLC from Greyrock Capital Group LLC, Lakeview Equity Partners LLC

Legal Advisor

Advised onChr. Hansen Holding A/S purchases UAS Laboratories LLC from Greyrock Capital Group LLC, Lakeview Equity Partners LLC

Clients

Covetrus, Inc. engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships and successful financial outcomes for veterinary professionals. The firm geographically operates through the segments: North America, Europe and Asia Pacific (APAC) & Emerging Markets. The company was founded by Benjamin J. Shaw in 2014 and is headquartered in Portland, ME.

Founded in 1982, Neogen Corporation (NASDAQ: NEOG) has grown to more than 600 employees in multiple U.S. and international locations, and a worldwide presence. Neogen develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company’s Lansing, Mich.-based Food Safety Division develops and markets dehydrated culture media, and rapid diagnostic test kits to detect foodborne bacteria, spoilage organisms, mycotoxins, food allergens, genetic modifications, drug residues, plant diseases, and sanitation concerns. Neogen’s Lexington, Ky.-based Animal Safety Division develops and markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides. Neogen’s GeneSeek subsidiary based in Lincoln, Neb., is the leading global provider of DNA testing for animal agribusiness and veterinary medicine. Neogen understands that its customers face serious consequences if their products are contaminated with any of a number of well-established or emerging threats, including dangerous bacteria, natural toxins, veterinary drug residues, unlabeled food allergens, rodent filth, sanitation concerns, broken veterinary needles or other contaminants. Neogen excels at helping to identify safety concerns in the vast and changing landscape of food and animal safety. Neogen sales representatives can help customers address a wide array of concern with a “one-stop shop” approach that is a big advantage in a business climate trending toward single-source suppliers. The company now has more than 200 diagnostic tests to offer customers, and a comprehensive line of complementary products and services, such as dehydrated culture media to go with unmatched customer support and training. Neogen employs a similar marketing strategy for its veterinary products, offering customers a wide variety of animal safety solutions. Neogen believes that maintaining earned trust is a combination of innovation and a continuous commitment to quality. Neogen’s quality management system is ISO 9001 certified, which communicates to the company’s worldwide customer base that it understands the quality standards customers expect, and is firmly committed to achieving those quality standards. In recognition of this success, Neogen has been repeatedly named to Forbes Magazine’s list of the Best Small Companies in America, and was chosen by the NASDAQ National Market to be included in its top tier of listed companies, the Global Select Market.

Genus applies biotechnology to advance the science of animal breeding. As the world leader in improving porcine and bovine stock, we play a crucial role in the global agricultural economy. The progeny of our robust and highly productive pigs and cattle enable Genus customers – farmers and food producers in 70 countries – to meet growing demand for meat and milk despite tightening constraints on resources available for food production.

Key Stats and Financials As of 2021
Market Capitalization
$10.3B
Total Enterprise Value
$13.2B
Earnings Per Share
$1.86
Revenue
$1.27B
Three Year Compounded Annual Growth Rate Of Revenue
-0.65%
Debt TEV
0.09x
TEVNet Income
53.97x
Enterprise Value EBITDAOperating
28.79x
Enterprise Value / Sales
10.4x
EBITDAMargin
36.11%
Total Equity
$1.92B
Total Debt
$1.13B
EBITDA
$459M
Net Profit
$245M
Investors
Details Hidden

Life Peer at United Kingdom House of Lords

Details Hidden

Ardian is an active manager which focuses exclusively on investing in unlisted companies and managing assets on behalf of third parties, aiming to provide long-term returns.The firm invests in buyouts of profitable high-potential companies valued between EUR 100 million and EUR 2 billion, generally taking a controlling interest, aiming to increase their growth and earnings in new markets.Ardian seeks to take controlling interests in small-cap buyouts in France, Germany and Italy, partnering with the investee company to add value and boost growth. They provide expansion capital by investing via minority interests in mature, profitable companies.Their Venture Capital team raises funds and consults innovative high-potential companies in the high-tech life sciences sector, making minority interest investments of EUR 2-5 million after receiving approval from the investment committee.They co-invest in buyout transactions involving companies valued at over EUR 500 million. The investment team constructs a diversified portfolio by sector, country, volume and type of transaction, taking minority interests in major LBOs in Europe and the US.For fund of funds, the firm performs in-house research, including track record, organization, employees and a review of individual assets in the portfolios, aiming to optimize investment in the best North American, European and Asian private equity funds.Ardian makes direct mezzanine investment in Europe as lead, co-investment and minority investor, partnering with other mezzanine funds to promote co-investment deals and increase the regional diversification of their portfolios.Their infrastructure team makes long-term investments of up to EUR 150 million in the transport, energy, water distribution and waste treatment sectors in European companies whose activity generates stable, foreseeable cash-flows.

Details Hidden

PAI is an active manager which focuses their investments on businesses with a strong European presence. The firm makes controlling equity investments in LBOs with transaction values generally between €500 million and several billion euros, aiming to invest in medium- to large-size public or private European companies in the services, consumer goods and capital goods sectors which have market leadership positions and an outstanding management team.PAI partners with their investee companies, aiming to add value by supporting the implementation of strategic and operational improvements, refocusing activities, targeting capital expenditure, marketing and R&D investments, evaluating new business opportunities, identifying add-on acquisitions and utilizing their network of industrial and financial contacts.While the firm participates actively in the key strategic decisions of their investee companies, they leave management in charge of the day-to-day running of the business and offer them attractive equity stakes and competitive performance-based compensation.

Suppliers
Novozymes A/S Other Business & Consulting Services | Copenhagen, Denmark

Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.

ADL Bionatur Solutions SA Chemicals | Jerez de la Frontera, Spain

ADL Bionatur Solutions SA operates as a biopharmaceutical company. It develops and produces active therapeutics substances. The company was founded in March 2005 and is headquartered in Jerez de la Frontera, Spain.

Novo Holdings A/S Biotechnology | Hellerup, Denmark

Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation’s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Chr. Hansen Holding A/S. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Chr. Hansen Holding A/S's profile does not indicate a business or promotional relationship of any kind between RelSci and Chr. Hansen Holding A/S.